Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics

Systematic review of intraperitoneal chemotherapy for gastric cancer

(2011) G. Matharu et al.   BRITISH JOURNAL OF SURGERY

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

(2011) Mark A. Morgan et al.   GYNECOLOGIC ONCOLOGY

Phase I Study of Biweekly Intravenous Paclitaxel plus Intraperitoneal Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Metastasis

(2011) Hironori Ishigami et al.   ONCOLOGY

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis

(2010) Jan Franko et al.   CANCER

Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding

(2010) Moon Ki Choi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Morbidity and Mortality With Cytoreductive Surgery and Intraperitoneal Chemotherapy

(2010) Faheez Mohamed et al.   CANCER JOURNAL

Phase II Study of Intraperitoneal Carboplatin With Intravenous Paclitaxel in Patients With Suboptimal Residual Epithelial Ovarian or Primary Peritoneal Cancer

(2010) Keiichi Fujiwara et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Catumaxomab

(2010) Rolf Linke et al.   mAbs

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis

(2009) H. Ishigami et al.   ANNALS OF ONCOLOGY

Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?

(2009) Terence C. Chua et al.   ANNALS OF SURGERY

Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009

(2009) Amy D. Tiersten et al.   GYNECOLOGIC ONCOLOGY

Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model

(2009) Danielle D. Jandial et al.   GYNECOLOGIC ONCOLOGY

Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer

(2009) Harriet O. Smith et al.   GYNECOLOGIC ONCOLOGY

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery

(2009) Yutaka Yonemura et al.   JOURNAL OF SURGICAL ONCOLOGY

Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer

(2009) Hironori Ishigami et al.   ONCOLOGY

Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

(2008) D. Elias et al.   BRITISH JOURNAL OF SURGERY

Review: Intracavitary Radioimmunotherapy to Treat Solid Tumors

(2008) Frits Aarts et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience

(2008) S. Scaringi et al.   EJSO

Hyperthermia adds to chemotherapy

(2008) Rolf D. Issels   EUROPEAN JOURNAL OF CANCER

Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer

(2008) S.B. HOWELL   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER